SE451428B - Injicerbar stabil vattenlosning med inflammationshemmande verkan och sett att framstella denna losning - Google Patents
Injicerbar stabil vattenlosning med inflammationshemmande verkan och sett att framstella denna losningInfo
- Publication number
- SE451428B SE451428B SE8002715A SE8002715A SE451428B SE 451428 B SE451428 B SE 451428B SE 8002715 A SE8002715 A SE 8002715A SE 8002715 A SE8002715 A SE 8002715A SE 451428 B SE451428 B SE 451428B
- Authority
- SE
- Sweden
- Prior art keywords
- acetic acid
- methoxy
- methylindole
- chlorobenzoyl
- solution
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/543—Lipids, e.g. triglycerides; Polyamines, e.g. spermine or spermidine
- A61K47/544—Phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19792914789 DE2914789A1 (de) | 1979-04-11 | 1979-04-11 | Injizierbare arzneimittel mit entzuendungshemmender wirkung |
Publications (2)
Publication Number | Publication Date |
---|---|
SE8002715L SE8002715L (sv) | 1980-10-12 |
SE451428B true SE451428B (sv) | 1987-10-12 |
Family
ID=6068138
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE8002715A SE451428B (sv) | 1979-04-11 | 1980-04-10 | Injicerbar stabil vattenlosning med inflammationshemmande verkan och sett att framstella denna losning |
Country Status (14)
Country | Link |
---|---|
US (1) | US4309420A (de) |
JP (1) | JPS55147217A (de) |
AT (1) | AT369650B (de) |
AU (1) | AU539043B2 (de) |
BE (1) | BE882732A (de) |
CA (1) | CA1136048A (de) |
CH (1) | CH642547A5 (de) |
DE (1) | DE2914789A1 (de) |
FR (1) | FR2453646A1 (de) |
GB (1) | GB2047535B (de) |
IT (1) | IT1148791B (de) |
NL (1) | NL8002096A (de) |
SE (1) | SE451428B (de) |
ZA (1) | ZA802158B (de) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3042365C2 (de) * | 1980-11-10 | 1987-01-29 | Extrakta Strauss GmbH, 2000 Hamburg | Flüssige, lecithinhaltige einphasige Mehrstoffsysteme und Verfahren zu ihrer Herstellung |
JPS59152348A (ja) * | 1983-02-19 | 1984-08-31 | Kaken Pharmaceut Co Ltd | ビフエニリルプロピオン酸エステル誘導体およびその製造法 |
US5196567A (en) * | 1983-02-19 | 1993-03-23 | Kaken Pharmaceutical Co., Ltd. | Biphenylylpropionic acid derivative, process for preparing the same and pharmaceutical composition containing the same |
CA1237670A (en) * | 1983-05-26 | 1988-06-07 | Andrew S. Janoff | Drug preparations of reduced toxicity |
US5059591B1 (en) * | 1983-05-26 | 2000-04-25 | Liposome Co Inc | Drug preparations of reduced toxicity |
JPS601122A (ja) * | 1983-06-20 | 1985-01-07 | Green Cross Corp:The | ビフエニリルプロピオン酸誘導体脂肪乳剤 |
PT78628B (en) * | 1984-05-02 | 1986-06-18 | Liposome Co Inc | Pharmaceutical composition with reduced toxicity |
IL79114A (en) * | 1985-08-07 | 1990-09-17 | Allergan Pharma | Method and composition for making liposomes |
IT1269569B (it) * | 1994-04-22 | 1997-04-08 | Ugo Citernesi | Procedimento per la preparazione di complessi fra fosfolipidi e principi attivi utili per la produzione di liposomi e principi attivi e liposomi ottenuti con il procedimento |
US5763422A (en) * | 1995-01-27 | 1998-06-09 | Board Of Regents, The University Of Texas System | Methods of enhancing the therapeutic activity of NSAIDS and compositions of zwitterionic phospholipids useful therein |
WO1996022780A1 (en) * | 1995-01-27 | 1996-08-01 | The Board Of Regents Of The University Of Texas System | Methods of enhancing the therapeutic activity of nsaids and compositions of zwitterionic phospholipids useful therein |
US5955451A (en) * | 1995-05-12 | 1999-09-21 | The University Of Texas System Board Of Regents | Methods of enhancing the therapeutic activity of NSAIDS and compositions of zwitterionic phospholipids useful therein |
US20040077604A1 (en) * | 2001-12-19 | 2004-04-22 | Lenard Lichtenberger | Method and compositions employing formulations of lecithin oils and nsaids for protecting the gastrointestinal tract and providingenhanced therapeutic activity |
WO2013049749A2 (en) | 2011-09-29 | 2013-04-04 | Plx Pharma Inc. | pH DEPENDENT CARRIERS FOR TARGETED RELEASE OF PHARMACEUTICALS ALONG THE GASTROINTESTINAL TRACT, COMPOSITIONS THEREFROM, AND MAKING AND USING SAME |
AU2021244695A1 (en) | 2020-03-26 | 2022-11-10 | Plx Opco Inc. | Pharmaceutical carriers capable of pH dependent reconstitution and methods for making and using same |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA725596A (en) * | 1960-08-26 | 1966-01-11 | J. Wretlind Arvid | Method of preparing intravenously injectable fat emulsions free from side reactions or complications |
GB1214515A (en) * | 1967-04-11 | 1970-12-02 | Sumitomi Chemical Company Ltd | Indole derivatives and salts thereof |
JPS5186117A (en) * | 1975-01-27 | 1976-07-28 | Tanabe Seiyaku Co | Johoseibiryushiseizainoseiho |
GB1523965A (en) * | 1976-03-19 | 1978-09-06 | Ici Ltd | Pharmaceutical compositions containing steroids |
US4093733A (en) * | 1976-09-09 | 1978-06-06 | Merck & Co., Inc. | Parenteral suspensions |
GB1575343A (en) * | 1977-05-10 | 1980-09-17 | Ici Ltd | Method for preparing liposome compositions containing biologically active compounds |
DE2856333C2 (de) * | 1978-12-27 | 1983-09-22 | A. Nattermann & Cie GmbH, 5000 Köln | Oral einnehmbare Arzneimittel mit entzündungshemmender Wirkung |
-
1979
- 1979-04-11 DE DE19792914789 patent/DE2914789A1/de active Granted
-
1980
- 1980-04-08 CA CA000349306A patent/CA1136048A/en not_active Expired
- 1980-04-08 GB GB8011633A patent/GB2047535B/en not_active Expired
- 1980-04-09 FR FR8007938A patent/FR2453646A1/fr active Granted
- 1980-04-10 JP JP4632280A patent/JPS55147217A/ja active Granted
- 1980-04-10 NL NL8002096A patent/NL8002096A/nl not_active Application Discontinuation
- 1980-04-10 IT IT21300/80A patent/IT1148791B/it active
- 1980-04-10 AU AU57330/80A patent/AU539043B2/en not_active Ceased
- 1980-04-10 AT AT0194780A patent/AT369650B/de not_active IP Right Cessation
- 1980-04-10 US US06/139,117 patent/US4309420A/en not_active Expired - Lifetime
- 1980-04-10 CH CH274580A patent/CH642547A5/de not_active IP Right Cessation
- 1980-04-10 BE BE0/200183A patent/BE882732A/fr not_active IP Right Cessation
- 1980-04-10 SE SE8002715A patent/SE451428B/sv not_active IP Right Cessation
- 1980-04-10 ZA ZA00802158A patent/ZA802158B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
FR2453646B1 (de) | 1985-01-25 |
DE2914789C2 (de) | 1991-05-29 |
BE882732A (fr) | 1980-07-31 |
AT369650B (de) | 1983-01-25 |
CH642547A5 (de) | 1984-04-30 |
DE2914789A1 (de) | 1980-10-16 |
SE8002715L (sv) | 1980-10-12 |
CA1136048A (en) | 1982-11-23 |
GB2047535A (en) | 1980-12-03 |
JPS55147217A (en) | 1980-11-17 |
IT8021300A0 (it) | 1980-04-10 |
FR2453646A1 (fr) | 1980-11-07 |
ZA802158B (en) | 1981-05-27 |
JPH0210805B2 (de) | 1990-03-09 |
AU5733080A (en) | 1980-10-16 |
GB2047535B (en) | 1983-10-26 |
AU539043B2 (en) | 1984-09-06 |
NL8002096A (nl) | 1980-10-14 |
US4309420A (en) | 1982-01-05 |
ATA194780A (de) | 1982-06-15 |
IT1148791B (it) | 1986-12-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA1144480A (en) | Stabilized parenterally administrable solutions | |
SE451428B (sv) | Injicerbar stabil vattenlosning med inflammationshemmande verkan och sett att framstella denna losning | |
EP3158867B1 (de) | Eine methode zur steigerung der wasserlösslichkeit einer bipshopshonsäure oder eines bisphosphonats | |
US5679690A (en) | Concentrated aqueous solutions of argatroban | |
KR890000115B1 (ko) | 수용성 약제 콤플렉스의 제조방법 | |
CA2364659A1 (en) | A pharmaceutical formulation comprising an bisphosphonate and an additive agent providing an enhanced absorption of the bisphosphonate | |
PT1827379E (pt) | Formulações contendo alquilfosfocolinas usando novos portadores de carga negativa | |
RU2013105783A (ru) | Парентеральные составы производных элацитарабина | |
JP3804452B2 (ja) | 肝炎治療剤 | |
FI83287B (fi) | Foerfarande foer framstaellning av ett farmaceutiskt preparat. | |
PT86644B (pt) | Processo para a preparacao de formulacoes secas contendo um sal de diclofenac | |
JPH02250876A (ja) | 2―フェニル―1,2―ベンズイソセレナゾール―3(2h)―オンの安定した非経口溶液及びその製造方法 | |
CN1129432C (zh) | 采用二硫醚降低碳铂的毒性作用 | |
US5720973A (en) | Preparation of colloidal aqueous solutions of active substances of low solubility and a lipid therefor | |
US6936273B2 (en) | Liposomal analgesic formulation and use | |
ES2283557T3 (es) | Medicamento que contiene una formulacion anhidra de un xantogenato. | |
EP0193414A2 (de) | Liposome, Verfahren zu deren Herstellung und sie enthaltende Mittel | |
JPH10505818A (ja) | リポソーム製剤 | |
WO2013046219A1 (en) | Pharmaceutical composition comprising lecithin and process for preparing thereof | |
MXPA01010085A (es) | Una formulacion farmaceutica que comprende un bisfosfonato y un agente aditivo que suministra una absorion creciente del bisfosfonato | |
JPH0469146B2 (de) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NUG | Patent has lapsed |
Ref document number: 8002715-4 Effective date: 19931110 Format of ref document f/p: F |